These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effects. van der Goes MC; Jacobs JW; Bijlsma JW Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S2. PubMed ID: 25608693 [TBL] [Abstract][Full Text] [Related]
24. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Silva CA; Bonfa E; Østensen M Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1682-90. PubMed ID: 20799266 [No Abstract] [Full Text] [Related]
25. [New concepts of steroid preparations--preclinical and clinical concepts]. Oshima H Nihon Naika Gakkai Zasshi; 2000 Feb; 89(2):374-80. PubMed ID: 10756655 [No Abstract] [Full Text] [Related]
26. [Current anti-rheumatism agents]. Tsvetkova ES Med Sestra; 1978 Jan; 37(1):17-9. PubMed ID: 306018 [No Abstract] [Full Text] [Related]
27. [Medicamentous therapy of rheumatic diseases in the spa?]. Pohl W Munch Med Wochenschr; 1966 Sep; 108(37):1809-12. PubMed ID: 4296918 [No Abstract] [Full Text] [Related]
29. [Glucocorticoid therapy in the course of time]. Kaiser H; Burmester GR; Buttgereit F Z Rheumatol; 2005 Apr; 64(3):147-8. PubMed ID: 15868330 [No Abstract] [Full Text] [Related]
31. Optimised glucocorticoid therapy: the sharpening of an old spear. Buttgereit F; Burmester GR; Lipworth BJ Lancet; 2005 Feb 26-Mar 4; 365(9461):801-3. PubMed ID: 15733723 [TBL] [Abstract][Full Text] [Related]
32. Series on pharmacology in practice. 9. Glucocorticoids in rheumatic disease. Nelson AM; Conn DL Mayo Clin Proc; 1980 Dec; 55(12):758-69. PubMed ID: 7012460 [TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Stahn C; Löwenberg M; Hommes DW; Buttgereit F Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118 [TBL] [Abstract][Full Text] [Related]
34. Effects of various anti-inflammatory and anti-rheumatic agents on the synthesis, secretion, and activity of a cartilage proteoglycan-degrading enzyme and other macrophage enzymes. Ackerman NR; Jubb SN; Marlowe SL Biochem Pharmacol; 1981 Aug; 30(15):2147-55. PubMed ID: 7028039 [No Abstract] [Full Text] [Related]
36. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Didonato JA; Saatcioglu F; Karin M Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 2):S11-5. PubMed ID: 8756781 [No Abstract] [Full Text] [Related]
37. [Immunosuppressive drugs, corticosteroids and pregnancy]. Gil S Rev Prat; 2012 Sep; 62(7):949-53. PubMed ID: 23236866 [TBL] [Abstract][Full Text] [Related]
38. Comparative study of ophthalmological and serological manifestations and the therapeutic response of patients with isolated scleritis and scleritis associated with systemic diseases. Sousa JM; Trevisani VF; Modolo RP; Gabriel LA; Vieira LA; Freitas Dd Arq Bras Oftalmol; 2011; 74(6):405-9. PubMed ID: 22331111 [TBL] [Abstract][Full Text] [Related]
39. The influence of treatment on the natural history of rheumatoid disease. Eade AW J R Coll Physicians Lond; 1976 Jan; 10(2):170-176. PubMed ID: 1082028 [No Abstract] [Full Text] [Related]
40. Immunosuppressive and anti-inflammatory effects of glucocorticoids. Fauci AS Monogr Endocrinol; 1979; 12():449-65. PubMed ID: 386088 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]